neuroleptic malignant syndrome 神经阻滞剂恶性综合征 ; 抗精神病药恶性综合征 ; 剂恶性综合征
Neuroleptic malignant syndrome NMS 恶性综合征
neuroleptic malignant-like syndrome 神经抑制剂恶性样综合征
nm neuroleptic malignant syndrome 抗精神病药恶性综合征
Neuroleptic malignant syndrome presenting features include: fever altered level of consciousness and "lead-pipe" skeletal muscle rigidity causing rhabdomyolysis.
抗精神病药物恶性症候群会引起意识改变、高烧、“铅管样”肌肉僵直并横纹肌溶解症。
These initial symptoms can overlap considerably with those of other cardiac and non-cardiac conditions, including neuroleptic malignant syndrome (NMS), which may itself be caused by antipsychotics.
这些始发症状可与其他的心脏和非心脏原因引起的疾病症状相叠加，包括可由抗精神病药物引起的抗精神病药恶性综合征。
Since the initial report of neuroleptic malignant syndrome (NMS) in 1960, lots of clinical data have been accumulated on the pathogenesis, manifestations and treatment of NMS.
自从1960年首次报道抗精神病药恶性综合征（ NMS）后，大量的临床案例已使人们对于NMS的发病机制、临床表现和治疗有了较深的了解。
应用推荐